Patent details

Basic Information

Publication number:

EP2227296

PCT Application Number:

PCT/US/2009/030291

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP097013643

PCT Publication Number:

WO/2009/089260

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION OF ANTI-CTLA4 ANTIBODY WITH TUBULIN MODULATING AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES

French Title of Invention:

COMBINAISON D'ANTICORPS ANTI-CTLA4 AVEC DES AGENTS DE MODULATION DE LA TUBULINE POUR LE TRAITEMENT DE MALADIES PROLIFÉRATIVES

German Title of Invention:

KOMBINATION AUS EINEM ANTI-CTLA4-ANTIKÖRPER UND TUBULINMODULIERENDEN WIRKSTOFFEN ZUR BEHANDLUNG PROLIFERATIVER ERKRANKUNGEN

SPC Number:

Dates

Filing date:

07/01/2009

Grant date:

25/11/2015

EP Publication Date:

25/11/2015

PCT Publication Date:

16/07/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/09/2010

EP B1 Publication Date:

25/11/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

07/01/2016

Expiration date:

07/01/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/01/2009

 

 

Name:

Bristol-Myers Squibb Company

Address:

Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Inventor

Name:

JURE-KUNKEL Maria

Address:

United States (US)

Priority

1

Priority Number:

19778 P

Priority Date:

08/01/2008

Priority Country:

United States (US)

2

Priority Number:

56957 P

Priority Date:

29/05/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

A61P 35/00;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages